Kwivik Therapeutics Partners with EirMed to Accelerate Product Commercialization
businessNews

Kwivik Therapeutics Partners with EirMed to Accelerate Product Commercialization

Jan 13, 2021

FRISCO, Texas, Jan. 13, 2021 /PRNewswire/ — Kwivik Therapeutics Inc (“Kwivik”), a medtech developer of disruptive technologies for respiratory and emergency medical markets today announced the Company has partnered with EirMed to accelerate commercialization of some of its therapeutics…


Continue Reading

Related Articles

businessNews WallSt

IRS delays start of tax filing season to Feb. 12

J Jan, 2021
businessNews WallSt

Amazon Will Let Companies Build Voice Assistants on Alexa

J Jan, 2021
businessNews

SKUP veröffentlicht positive Bewertung des LumiraDx SARS-CoV-2-Antigentests für symptomatische und asymptomatische Personen

J Jan, 2021

News You Missed

zerohedge

Many Vaccine Sites Stop Checking ID, Flout State Guidelines, As Shots Not Reaching Public Fast Enough

Jan 15, 2021 HEDGE
WallSt

Lori Loughlin's husband is asking to serve the rest of his prison sentence at home after he spent 56 days in solitary confinement over COVID-19 concerns

Jan 15, 2021 HEDGE
WallSt

Bumble files to go public

Jan 15, 2021 HEDGE
News

Authorities at former Nazi German concentration camp Buchenwald warn revelers against sledding over MASS GRAVES

Jan 15, 2021 HEDGE
HEDGE accordingly